November 13, 2021Open Access

Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes

Key Points

Key points are not available for this paper at this time.

Abstract

This study shows that tumor classification by gene expression profiling and molecular subtyping can identify patients who are more likely to benefit from chemotherapy before radical cystectomy for muscle-invasive bladder cancer. Together with other markers for response, molecular subtypes could have a role in selective administration of such chemotherapy.

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper

Cite This Study

Sjödahl et al. (Sat,) studied this question.

synapsesocial.com/papers/69dea5a8499d77a496b0c3b1 https://doi.org/https://doi.org/10.1016/j.eururo.2021.10.035

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA2019 · 49 citations
2Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer2009 · 46 citations
3Predicting Response to Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy for Bladder Cancers through Genome-Wide Gene Expression Profiling2005 · 240 citations
4multiclassPairs: an R package to train multiclass pair-based classifier2021 · 25 citations
5Association between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes following Radical Cystectomy: Systematic Review and Meta-Analysis2020 · 51 citations

KI fragen

Bookmark

View Full Paper